ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill replace chemo for some breast cancers? major trial launches
Disease control Recruiting nowThis study compares two treatments for people with high-stage, estrogen-positive, HER2-negative breast cancer that has a low genetic risk of returning. One group gets standard hormone therapy plus a targeted pill (ribociclib), while the other gets chemotherapy first, then the sam…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
Could a common mushroom help fight breast cancer? new trial investigates
Disease control Recruiting nowThis phase 2 trial is testing whether turkey tail mushroom extract can slow or shrink estrogen receptor-positive, HER2-negative breast cancer in post-menopausal women. Forty participants will take the supplement between diagnosis and surgery, and researchers will measure changes …
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could breast cancer patients avoid surgery? new trial tests less treatment
Disease control Recruiting nowThis study is for people with certain types of breast cancer (HER2-positive or triple-negative) who have a complete response to initial drug therapy. It tests whether they can safely skip surgery and only receive radiation, or skip radiation if surgery shows no cancer left. For a…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Zapping cancer spots: new radiation strategy may extend current Drug's power
Disease control Recruiting nowThis study tests whether precise radiation (SBRT) can treat a few growing tumors in patients with ER+ breast cancer that has spread, allowing them to continue their current medication longer. About 18 adults with limited disease progression will receive SBRT and be monitored. The…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a lower tamoxifen dose prevent breast cancer in high-risk women?
Prevention Recruiting nowThis study is for premenopausal women at higher-than-average risk for breast cancer. It tests whether a low dose of tamoxifen can safely reduce breast density, which is linked to cancer risk. About 200 women will take tamoxifen, and doctors will adjust the dose if needed to get t…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Can a mushroom ease breast cancer treatment side effects?
Symptom relief Recruiting nowThis study tests whether Reishi mushroom extract can reduce fatigue and joint pain in breast cancer patients taking aromatase inhibitors. About 80 women with moderate to severe fatigue will receive either the mushroom extract or a placebo for 8 weeks. The goal is to see if this n…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
CBD oil tested for breast cancer drug side effect
Symptom relief Recruiting nowThis study tests whether a high-CBD plant extract can reduce joint stiffness and pain in women with breast cancer who take aromatase inhibitors. These drugs lower estrogen to prevent cancer return but often cause painful joints, leading some women to stop treatment. The trial wil…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Breast cancer drug's skin side effects under the microscope
Knowledge-focused Recruiting nowThis study looks at how aromatase inhibitor therapy changes skin quality and self-esteem in breast cancer survivors. Researchers will use skin imaging and surveys to track changes in 35 women starting this hormone therapy. The goal is to better understand and manage these side ef…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC